中国P站

Immunosenescence; Immune Aging; Inflammaging; Cellular Senescence; T Cell Senescence; B Cell Senescence; Innate Immunity; Adaptive Immunity; Vaccine Efficacy; Gut Microbiome

Introduction

Immune aging, also known as immunosenescence, represents a significant decline in the immune system's functionality over time. This decline leads to increased susceptibility to infections, reduced effectiveness of vaccines, and a heightened risk of developing age-related conditions such as cancer and autoimmune disorders [1].

A central feature of aging is the persistent, low-grade inflammatory state termed 'inflammaging.' This chronic inflammation is a key contributor to the pathogenesis of numerous age-related diseases, promoting cellular dysfunction and tissue damage [2].

A critical component of immunosenescence is T cell senescence, which involves a reduction in the repertoire of functional T cells. This manifests as a decrease in naive T cells and an accumulation of memory and effector T cells with impaired proliferative and cytokine-producing capacities [3].

B cell immunosenescence is characterized by a diminished diversity of the B cell repertoire and a compromised ability to produce effective antibodies, particularly against novel antigens. This impacts the body's defense against new pathogens [4].

The innate immune system is not spared from age-related changes, affecting crucial cells like neutrophils, macrophages, and natural killer (NK) cells. These alterations can impair pathogen recognition and clearance while promoting excessive inflammatory responses [5].

Cellular senescence, an irreversible state of cell cycle arrest, plays a substantial role in both immunosenescence and inflammaging. Senescent cells accumulate with age and release pro-inflammatory molecules, exacerbating chronic inflammation [6].

The gut microbiome, which profoundly influences immune system development and function, undergoes age-related alterations. Dysbiosis, or an imbalance in gut microbiota, can contribute to inflammaging and negatively impact immune responses [7].

Responses to vaccines are notably diminished in older adults due to immunosenescence. This reduced efficacy against common infectious diseases is a significant public health challenge, necessitating strategies to improve vaccine effectiveness [8].

Immunometabolism, the intricate relationship between immune cell function and metabolic processes, is increasingly recognized as vital in immune aging. Age-related metabolic shifts can impair immune cell energy production and signaling pathways [9].

Research into interventions to combat immune aging is rapidly advancing. These strategies aim to reverse or mitigate immunosenescence through lifestyle modifications, pharmacological agents, and targeted immune pathway interventions, with the goal of extending healthspan [10].

Description

Immunosenescence, the multifaceted decline of the immune system with age, presents a significant challenge, characterized by impaired defense mechanisms against pathogens and an increased propensity for age-related diseases [1].

This decline affects both the innate and adaptive branches of immunity, leading to a state where the body is less equipped to handle infections and more susceptible to chronic inflammatory conditions. Inflammaging, a persistent low-grade inflammatory state, is a defining characteristic of aging and a principal driver of age-related pathologies. It fuels cellular dysfunction and tissue damage, creating a detrimental cycle that accelerates the aging process and contributes to a weakened immune system [2].

T cell senescence significantly contributes to immunosenescence by reducing the pool of functional T cells. This leads to a diminished capacity for adaptive immunity, impacting the ability to respond effectively to new infections and potentially contributing to autoimmune responses [3].

Similar to T cells, B cells undergo immunosenescence, resulting in a reduced diversity of B cell populations and impaired antibody production. This compromise in humoral immunity makes individuals more vulnerable to infections and reduces the effectiveness of vaccination strategies [4].

The innate immune system also exhibits age-related functional deficits. Changes in cells such as macrophages and NK cells can lead to both a weakened ability to fight off pathogens and an exaggerated inflammatory response, further contributing to age-related health issues [5].

Cellular senescence, a state of irreversible growth arrest, contributes to the aging immune system by promoting inflammation. Senescent cells secrete a cocktail of inflammatory molecules (SASP) that drives chronic inflammation and tissue damage, impacting overall immune homeostasis [6].

The gut microbiome's composition and function change with age, leading to dysbiosis. This imbalance can profoundly influence immune cell development and function, contributing to inflammaging and systemic inflammation, highlighting the critical link between gut health and immunity [7].

The diminished efficacy of vaccines in older adults is a direct consequence of immunosenescence. This age-related decline in immune responsiveness poses a public health concern, particularly for infectious diseases, and necessitates the development of improved vaccination strategies [8].

Immunometabolism, the interaction between cellular metabolism and immune function, is crucial for understanding immune aging. Age-associated metabolic alterations can hinder the energy requirements for optimal immune cell performance, suggesting metabolic pathways as potential therapeutic targets [9].

Strategies aimed at combating immune aging are diverse, encompassing lifestyle interventions, pharmacological treatments like senolytics, and immunomodulatory approaches. The overarching objective is to preserve immune competence and extend healthspan by maintaining a robust immune system throughout life [10].

Conclusion

Immunosenescence, or immune aging, is characterized by a decline in immune function, leading to increased susceptibility to infections, reduced vaccine efficacy, and a higher risk of age-related diseases. This process involves changes in both innate and adaptive immunity, including 'inflammaging,' a chronic low-grade inflammation. Key aspects include T cell and B cell senescence, impaired innate immune cell function, and the accumulation of senescent cells. Age-related gut dysbiosis and shifts in immunometabolism also contribute to immune dysfunction. Vaccine responses are significantly impaired in older adults. Current research focuses on interventions such as lifestyle changes, senolytics, and immunomodulatory drugs to combat immune aging and promote healthspan.

References

1. Carbone, JO, Lio, CY, Miller, JP. (2021) .Immunol. Rev. 302:145-175.

   , ,

2. Franceschi, C, Campisi, J, Li, W. (2020) .Int. J. Mol. Sci. 21:7072.

   , ,

3. Perez-Quitian, AM, Ramos-Corral, GA, Fernandez-Garcia, ML. (2022) .Ageing Res. Rev. 73:101557.

   , ,

4. Hsu, HC, Ye, W, Lee, MC. (2021) .Front. Immunol. 12:612456.

   , ,

5. Henao-Restrepo, AM, Pui, CH, Evans, J. (2020) .Nat. Rev. Immunol. 20:609-624.

   , ,

6. Luz-Moreira, J, Gomes, MG, Pereira, SL. (2022) .Cell. Mol. Immunol. 19:1372-1387.

   , ,

7. Claesson, MJ, Saeed, A, Sonnenburg, JL. (2021) .Nat. Rev. Gastroenterol. Hepatol. 18:578-591.

   , ,

8. Lee, JS, Kim, S, Park, EJ. (2023) .Vaccine 41:5180-5189.

   , ,

9. Chakraborty, S, Nair, S, Chattopadhyay, S. (2022) .Trends. Mol. Med. 28:1172-1186.

   , ,

10. Mishra, S, Devanathan, S, Patel, PK. (2021) .Ageing. Dis. 12:1195-1211.

    , ,